Raffaella Molteni
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 54 publications
Drug development in systemic sclerosis: novel therapeutics to watch.
Journal: Expert review of clinical immunology
Published: February 21, 2026
High-throughput plasma proteomics reveals circulating biomarkers of interstitial lung disease and progressive pulmonary fibrosis in systemic sclerosis.
Journal: Annals of the rheumatic diseases
Published: February 20, 2026
Decoding VEXAS syndrome: emerging insights into pathogenesis and clinical management.
Journal: Current opinion in rheumatology
Published: November 01, 2025
Clonal hematopoiesis meets an autoinflammatory disease: the new paradigm of VEXAS syndrome.
Journal: Expert review of hematology
Published: May 21, 2025
The neurobiology of major depressive disorder: Updates and perspectives from proteomics.
Journal: Progress in neurobiology
Published: March 04, 2025
Mechanisms of hematopoietic clonal dominance in VEXAS syndrome.
Journal: Nature medicine
Published: July 08, 2024
Activity-based anorexia (ABA) model: Effects on brain neuroinflammation, redox balance and neuroplasticity during the acute phase.
Journal: Neurochemistry international
Published: April 29, 2024
The Natural Protoalkaloid Methyl-2-Amino-3-Methoxybenzoate (MAM) Alleviates Positive as well as Cognitive Symptoms in Rat and Mouse Schizophrenia Models.
Journal: Current neuropharmacology
Published: October 13, 2022
Myelomonocytic cells in giant cell arteritis activate trained immunity programs sustaining inflammation and cytokine production.
Journal: Rheumatology (Oxford, England)
Published: September 15, 2022
Last Updated: 09/26/2026